Vascular Closure Systems Inc. announced the successful conclusion of Phase I and Phase II of the first-in-human (FIH) clinical trial for its 6/7 French FastSeal Bioabsorbable Vascular Access Closure System, achieving a 100 percent success rate throughout both phases of the clinical trial, with exceptional time to hemostasis (TTH) and time to ambulation (TTA).
The U.S. Food and Drug Administration (FDA) is notifying healthcare professionals, caregivers and patients about a change to the container and carton labels for heparin products.
Imaging Technology News experts discuss the trends and latest technology they saw on the show floor and in sessions at ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
One-year results from the ADAPT-DES Trial were presented during TCT 2012. It examined patient hyporesponsiveness to ...
Increasingly software applications are providing many of the major advancements in magnetic resonance imaging (MRI) rather than hardware. In recent years, this has translated into software that enables physicians to do more in less time, extract more diagnostic information from imaging exams and provide more accurate quantification. While a hospital may not spend millions to upgrade its MRI system, it frequently takes advantage of the lower cost option of other vendors’ software to assess and manipulate those images.
Two key news items in September made me think about the future direction of hemodynamic support, and that intra-aortic balloon pumps (IABP) will increasingly face a more serious challenge from small percutaneous left ventricular assist devices (pLVAD). This was reinforced when I received a cardiology market analysis from GlobalData agreeing with this assessment.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
There were several evident trends on the show floor at RSNA 2012, including interest in software fueled by Stage 1 and 2 meaningful use requirements, new mammography solutions and innovations in imaging hardware.
More than half of patients treated for claudication or critical limb ischemia (CLI) with stenting of the superficial femoral artery (SFA) had primary patency at five years, says a recent study.
Featuring hovercraft-like C-arm movement and the unique Access Halo, the WorkRite technology on Toshiba America Medical Systems Inc.’s Infinix-i cardiovascular X-ray systems makes interventional procedures easier for clinicians and improves patient care.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Tryton Medical Inc. announced the completion of enrollment in the TRYTON Pivotal U.S. Food and Drug Administration (FDA) IDE trial evaluating the Tryton Side Branch Stent.
Volcano Corporation announced that it has entered into a definitive agreement to acquire Sync-Rx Ltd., a privately-held company based in Israel that develops advanced software applications that optimize and facilitate transcatheter cardiovascular interventions using automated online image processing. It is anticipated the transaction will close within the next 30 days.
December 6, 2012 — Neusoft Medical Systems Co. Ltd., a wholly owned subsidiary of Neusoft Corp., announced this week that its NeuViz 64 multi-slice computed tomography (CT) scanner has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
December 6, 2012 — Daiichi Sankyo Inc. and Eli Lilly and Co. announced results of two retrospective studies comparing rates of readmission for subsequent heart attack and initial hospitalization costs among patients with acute coronary syndromes (ACS) treated with a percutaneous coronary intervention (PCI) and antiplatelet therapy.
Giving clinicians a more complete picture while improving safety during interventional procedures, Toshiba America Medical Systems Inc. introduces Spot Fluoroscopy for its Infinix-i systems. Enabling quicker diagnoses and lower dose, clinicians can observe a target region of anatomy using Spot Fluoro’s live fluoroscopy while viewing the last image hold (LIH) surrounding area.
The U.S. Food and Drug Administration (FDA) granted premarket approval (PMA) for the HeartWare Ventricular Assist System (VAS) designed as a bridge to cardiac transplantation.